Nemes Rush Group’s CorMedix CRMD Stock Holding History

Nemes Rush Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7K	Hold	2,000	–	–	﹤0.01%	515
2026 Q1	$13.6K	Hold	2,000	–	–	﹤0.01%	511
2025 Q4	$23.3K	Hold	2,000	–	–	﹤0.01%	447
2025 Q3	$23.3K	Hold	2,000	–	–	﹤0.01%	414
2025 Q2	$24.6K	Hold	2,000	–	–	﹤0.01%	401
2025 Q1	$12.3K	Hold	2,000	–	–	﹤0.01%	448
2024 Q4	$16.2K	Hold	2,000	–	–	﹤0.01%	415
2024 Q3	$8.48K	Hold	2,000	–	–	﹤0.01%	417
2024 Q2	$8.66K	Hold	2,000	–	–	﹤0.01%	420
2024 Q1	$8.48K	Hold	2,000	–	–	﹤0.01%	452
2023 Q4	$7.52K	Hold	2,000	–	–	﹤0.01%	450
2023 Q3	$7.4K	Hold	2,000	–	–	﹤0.01%	437
2023 Q2	$7.93K	Buy	+2,000	New	+$9.89K	﹤0.01%	450

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nemes Rush Group's CRMD Position: Q2 2026 in Review

Nemes Rush Group held its CorMedix (CRMD) position steady in Q2 2026 at 2,000 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

Nemes Rush Group first reported a position in CRMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $24.6K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Nemes Rush Group held 2,000 shares of CorMedix worth $15.7K as of Q2 2026.
Nemes Rush Group left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #515 holding.
Nemes Rush Group first reported a position in CorMedix in Q2 2023 and has held it in 13 quarters since.
Nemes Rush Group's CorMedix position peaked at $24.6K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.